These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3889973)

  • 1. Pharmacotherapy and mental retardation/developmental disability: a bibliography. (Special emphasis on non-institutionalized populations).
    Reatig N
    Psychopharmacol Bull; 1985; 21(2):329-33. PubMed ID: 3889973
    [No Abstract]   [Full Text] [Related]  

  • 2. A national study of prescribed drugs in institutions and community residential facilities for mentally retarded people.
    Hill BK; Balow EA; Bruininks RH
    Psychopharmacol Bull; 1985; 21(2):279-84. PubMed ID: 4001292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and prediction of psychotropic drug use in California developmental centers.
    Stone RK; Alvarez WF; Ellman G; Hom AC; White JF
    Am J Ment Retard; 1989 May; 93(6):627-32. PubMed ID: 2719845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Learning disabilities. Challenging service.
    Matthews DR
    Nurs Times; 1995 Jun 7-13; 91(23):59-61. PubMed ID: 7603881
    [No Abstract]   [Full Text] [Related]  

  • 5. Mental retardation. Behavior problems and psychotropic drugs.
    Rothman CB; Chusid E; Giannini MJ
    N Y State J Med; 1979 Apr; 79(5):709-15. PubMed ID: 286168
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychoactive drug use in public and community residential facilities for mentally retarded persons.
    Intagliata J; Rinck C
    Psychopharmacol Bull; 1985; 21(2):268-78. PubMed ID: 4001291
    [No Abstract]   [Full Text] [Related]  

  • 7. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons.
    Inoue F
    Ment Retard; 1982 Apr; 20(2):70-4. PubMed ID: 7078402
    [No Abstract]   [Full Text] [Related]  

  • 8. Establishing socially validated drug research in community settings.
    Agran M; Martin JE
    Psychopharmacol Bull; 1985; 21(2):285-90. PubMed ID: 3889971
    [No Abstract]   [Full Text] [Related]  

  • 9. Issues in psychopharmacology with the mentally retarded.
    Mouchka S
    Psychopharmacol Bull; 1985; 21(2):262-7. PubMed ID: 4001290
    [No Abstract]   [Full Text] [Related]  

  • 10. Trimonam and mental retardation.
    Huston I; Swett C; Cole JO
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):70-2. PubMed ID: 401715
    [No Abstract]   [Full Text] [Related]  

  • 11. Issues and future research directions of pharmacotherapy in mental retardation.
    Schroeder SR
    Psychopharmacol Bull; 1985; 21(2):323-6. PubMed ID: 4001293
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of psychotropic medication among individuals with mental retardation].
    Baasland G; Engedal K
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1751-3. PubMed ID: 19756056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
    Meins W
    Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pervasive developmental disorder, behavior problems, and psychotropic drug use in children and adolescents with mental retardation.
    de Bildt A; Mulder EJ; Scheers T; Minderaa RB; Tobi H
    Pediatrics; 2006 Dec; 118(6):e1860-6. PubMed ID: 17142506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic management of psychiatric and behavioral symptoms in mental retardation.
    Madrid AL; State MW; King BH
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):225-43, x-xi. PubMed ID: 10674198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychoactive drug use in an institution for intellectually handicapped persons.
    Curtis JM
    Med J Aust; 1992 Jan; 156(1):69. PubMed ID: 1637368
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward a functional analysis of drug treatment for behavior problems of people with developmental disabilities.
    Schaal DW; Hackenberg T
    Am J Ment Retard; 1994 Sep; 99(2):123-40. PubMed ID: 7803030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric illness in mental retardation: an update on pharmacotherapy.
    Masi G; Luccherino L
    Panminerva Med; 1997 Dec; 39(4):299-304. PubMed ID: 9478071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of children.
    Lipman RS
    Psychopharmacol Bull; 1971 Apr; 7(2):14-27. PubMed ID: 4942081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.